Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study

Introduction: To analyze the feasibility and efficacy of sleeve lobectomy after neoadjuvant immunotherapy in multicenter patients with squamous cell lung cancer. Methods: We retrospectively identified patients who received neoadjuvant immunotherapy (n = 14) or chemotherapy alone (n = 33) at five tho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tianxiang Chen, MD, PhD, Junwei Ning, MD, Jianfei Shen, MD, PhD, Hui Pan, MD, Linhai Fu, MD, Enwu Xu, MD, PhD, Han Wu, MD, Jia Huang, MD, PhD, Yunhai Yang, MD, PhD, Ziming Li, MD, PhD, Qingquan Luo, MD, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-04-01
coleção:	JTO Clinical and Research Reports
Assuntos:	Neoadjuvant therapy Sleeve lobectomy Squamous cell lung cancer PD-1 inhibitor
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666364323000115
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!